Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Reexamination Certificate
2011-06-14
2011-06-14
Landau, Sharmila Gollamudi (Department: 1611)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Reexamination Certificate
active
07960366
ABSTRACT:
Methods and compositions for treating for the synergistic treatment of fungal associated disorders are discussed.
REFERENCES:
patent: 2980584 (1961-04-01), Hammer
patent: 2990331 (1961-06-01), Neumann et al.
patent: 3062717 (1962-11-01), Hammer
patent: 3165531 (1965-01-01), Blackwood et al.
patent: 3454697 (1969-07-01), Joyner et al.
patent: 3557280 (1971-01-01), Weber et al.
patent: 3674859 (1972-07-01), Beutel et al.
patent: 3957980 (1976-05-01), Noseworthy
patent: 4018889 (1977-04-01), Armstrong
patent: 4024272 (1977-05-01), Rogalski et al.
patent: 4126680 (1978-11-01), Armstrong
patent: 4168206 (1979-09-01), Boyer
patent: 5362754 (1994-11-01), Raad et al.
patent: 5532227 (1996-07-01), Golub et al.
patent: 5639742 (1997-06-01), Lee et al.
patent: 5688516 (1997-11-01), Raad et al.
patent: 5789395 (1998-08-01), Amin et al.
patent: 5834450 (1998-11-01), Su
patent: 5989522 (1999-11-01), Friedman
patent: 6500812 (2002-12-01), Nelson et al.
patent: 6509319 (2003-01-01), Raad et al.
patent: 6617318 (2003-09-01), Nelson et al.
patent: 6624168 (2003-09-01), Nelson et al.
patent: 6642270 (2003-11-01), Nelson et al.
patent: 6683068 (2004-01-01), Nelson et al.
patent: 6818634 (2004-11-01), Nelson et al.
patent: 6818635 (2004-11-01), Nelson et al.
patent: 6833365 (2004-12-01), Levy et al.
patent: 6841546 (2005-01-01), Draper et al.
patent: 6846939 (2005-01-01), Nelson et al.
patent: 6849615 (2005-02-01), Nelson et al.
patent: 7001918 (2006-02-01), Huss et al.
patent: 7045507 (2006-05-01), Draper et al.
patent: 7056902 (2006-06-01), Nelson et al.
patent: 7067681 (2006-06-01), Nelson et al.
patent: 7094806 (2006-08-01), Nelson
patent: 2002/0031601 (2002-03-01), Darouiche et al.
patent: 2002/0123637 (2002-09-01), Levy et al.
patent: 2002/0128237 (2002-09-01), Nelson et al.
patent: 2002/0128238 (2002-09-01), Nelson et al.
patent: 2002/0132798 (2002-09-01), Nelson et al.
patent: 2002/0147182 (2002-10-01), Nelson et al.
patent: 2004/0048835 (2004-03-01), Nelson et al.
patent: 2004/0063674 (2004-04-01), Levy et al.
patent: 2004/0092490 (2004-05-01), Draper et al.
patent: 2004/0138183 (2004-07-01), Nelson et al.
patent: 2004/0152674 (2004-08-01), Levy et al.
patent: 2004/0176334 (2004-09-01), Nelson et al.
patent: 2004/0214800 (2004-10-01), Levy et al.
patent: 2004/0214801 (2004-10-01), Nelson et al.
patent: 2004/0242548 (2004-12-01), Draper et al.
patent: 2004/0266740 (2004-12-01), Huss et al.
patent: 2005/0020545 (2005-01-01), Draper et al.
patent: 2005/0026875 (2005-02-01), Nelson et al.
patent: 2005/0026876 (2005-02-01), Nelson et al.
patent: 2005/0038002 (2005-02-01), Nelson et al.
patent: 2005/0070510 (2005-03-01), Draper et al.
patent: 2005/0119235 (2005-06-01), Nelson et al.
patent: 2005/0137174 (2005-06-01), Ohemeng et al.
patent: 2005/0143352 (2005-06-01), Nelson et al.
patent: 2005/0143353 (2005-06-01), Nelson et al.
patent: 2005/0187198 (2005-08-01), Nelson et al.
patent: 2005/0215532 (2005-09-01), Levy et al.
patent: 2005/0250744 (2005-11-01), Levy et al.
patent: 2005/0282787 (2005-12-01), Myers et al.
patent: 2005/0288262 (2005-12-01), Bandarage et al.
patent: 2006/0003971 (2006-01-01), Nelson
patent: 2814974 (1978-10-01), None
patent: 2820983 (1979-10-01), None
Lew, M. A. et al., “Antifungal activity of four tetracycline analogues aganistCandida albicansin vitro: Potentiation by amphotericin B”, The Journal of Infectious Diseases, 1977, vol. 136, No. 2, pp. 263-270.
R.A. Araviiskii et al., “Combined effect of amphotericin B and metacydine onCandida albicanscells”, Antibiotiki, vol. 29 (3), pp. 198-201 (1984), see enclosed abstract.
Vazquez JA. Combination antifungal therapy against candida species: the new frontier—are we there yet? Med Mycol. Oct. 2003; 41(5):355-68, abstract only.
Kauffman CA. Clinical efficacy of new antifungal agents. Current Opinion in Microbiology. 2006. 9:483-488.
Johnson et al. Combination antifungal therapy: what can and should we expect. Bone Marrow Transplantation. 2007;40:297-306, abstract only.
Lupi et al. Tropical dermatology: Fungal tropical diseases. Journal of the American Academy of Dermatology. 2005;53(6):931-951, pp. 1-35.
Balani et al. Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine. Drug Metabolism and Disposition. 2000;28(111):1274-1278.
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry (Doerge RF, editor). 1982; pp. 151-159; and 268-278.
Huppert et al. Combined amphotericin B-Tetracylcine therapy for experimental coccidiodomycosis. Antimicrobial. Agents and Chemotherapy. 1974;5(5):473-478.
Lew et al. (“Antifungal activity of four tetracycline analogues againstCandida albicansin virto: Potentiation by Amphotericin B” Journal of Infectious Diseases, 1977, 136(2), 263-270).
Hughes, C.E. et al, “Enhancement of the in vitro activity of amphotericin B againstAspergillusspp. by tetracycline analogs,”Antimicrob. Agents Chemother., vol. 26(6):837-840 (1984).
Huppert, M. et al, “Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis,”Antimicrob. Agents Chemother., vol. 5(5):473-478 (1974).
Koza, D.J. et al, “Synthesis of 7-Substituted Tetracycline Derivatives,”Organic Letters, vol. 2(6):815-817 (2000).
Koza, D.J. et al, “Synthesis and biological evaluation of 9-substituted tetracycline derivatives,”Bioorganic&Medicinal Chemistry Letters, vol. 12:2163-2165 (2002).
Kwan, C.N. et at, “Potentiation of the antifungal effects of antibiotics by amphotericin B,”Antimicrob. Agents Chemother., vol. 2(2):61-65 (1972).
Lavarde, V. et al, “Effect of minocycline onCandida albicans. ‘in vitro’ study: comparison with tetracycline,”Pathol. Biol., vol. 23(9):725-728 (1975).
Lew, M.A. et al, “Antifungal activity of four tetracycline analogues againstCandida albicansin vitro: Potentiation by amphotericin B,”J. Infect. Dis., vol. 136(2):263-270 (1977).
Lew, M.A. et al, “Combined activity of minocycline and amphotericin B in vitro against medically imported yeasts,”Antimicrob. Agents Chemother., vol. 14(3):465-469 (1978).
Nelson, M.L. et al, “Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines,”J. Med. Chem., vol. 36(3):370-377 (1993).
Roy, S., “Use of tetracycline sorbate for the treatment ofAspergillus fumigatusinfection in broiler chicks,”Br. Vet. J., vol. 147:549-555 (1991).
Schwartz, S.N. et al, “Antifungal properties of polymyxin B and its potentiation of tetracyclines as an antifungal agent,”Antimicrobial agents and chemotherapy, vol. 2:36-40 (1972).
Thong, Y.H. et al, “Synergism between tetracycline and amphotericin B in experimental amoebic meningoencephalitis,”Med. J. Aust., vol. 1:663-664 (1978).
Waterworth, P.M., “The effect of minocycline onCandida albicans,” J. Clin. Path., vol. 27:269-272(1974).
Denning, D.W., “Echinocandins and pneumocandins—a new antifungal class with a novel mode of action”,J. Antimicrob. Chemother., 40:611-614 (1997).
Graybill, J.R., “The role of murine models in the development of antifungal therapy for systemic mycoses”,Drug Resistance Updates, 3:364-383 (2000).
Groll et al., “Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbits”,Antimicorb. Agents Chemother., 42(10):2700-2705 (1998).
Sheehan et al., “Current and emerging azole antifungal agents”,Clin. Microbiol. Rev., 12(1):40-79 (1999).
Draper Michael
Nelson Mark L.
Elrifi Ivor R.
Erlacher Heidi A.
Klinkel Kortney L
Landau Sharmila Gollamudi
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Substituted tetracycline compounds as synergistic antifungal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetracycline compounds as synergistic antifungal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetracycline compounds as synergistic antifungal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672624